Authors urge screening at the time of diabetes diagnosis
FRIDAY, Feb. 18, 2022 (HealthDay News) – Approximately one in five girls with type 2 diabetes has polycystic ovary syndrome (PCOS), according to a systematic review and meta-analysis published online Feb. 15 in JAMA Network Open.
Milena Cioana, from McMaster University in Hamilton, Ontario, Canada, and colleagues conducted a systematic literature review to determine the prevalence of PCOS in girls with type 2 diabetes and to assess the association of obesity and race with this prevalence.
Based on six studies (470 girls with type 2 diabetes), the researchers found that the prevalence of PCOS was 19.58 percent. When excluding studies that did not report PCOS diagnostic criteria, the calculated prevalence was 24.04 percent. Results should be considered with caution because of the studies that did not report the criteria used to diagnose PCOS, which is a challenge during adolescence.
“It is critical that active screening for PCOS in girls with type 2 diabetes is initiated at diabetes diagnosis and follows international evidence-based guidelines for diagnosing PCOS in adolescents,” the authors write. “The associations of obesity and race with PCOS prevalence among girls with type 2 diabetes need further evaluation to help define at-risk subgroups and implement early assessment and treatment strategies to improve management of this type 2 diabetes-related comorbidity.”
.jpg)
Considerable Gaps Reported in Care for Youth With Opioid Use Disorder 
GLP-1 Receptor Agonists, SGLT-2is Slow Renal Function Decline in T2D With Albuminuria 
Nutritional Deficiencies Seen in Youth Taking GLP-1 Receptor Agonists 
Genetics, Diabetes Tied to MASLD-Associated Cirrhosis Before Age 50 
Steatotic Liver Disease Risk Scores Compared for Predicting Cirrhosis 
Cirrhosis Can Recur After Liver Transplant 
Family History of CRC Increases CRC Risk Similarly in IBD, General Population 
Study IDs Risk Factors for Ketoacidosis in Adults With T2D Receiving SGLT2 Inhibitors 
.jpg)